Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would take into consideration new talks with insurers with regards to the list rates of Wegovy and copyright whenever they pledge to keep the medicines on their formularies. https://kethek.com/